Rami Lutfi, MD, a bariatric and general surgeon and medical director for bariatric and general surgery at Carrum Health
Or, you could represent an insurer who needs to know the information from the other end
For some people, microdosing GLP-1 medications may work for their health goals
More than a century later, the company became a leader in incretin biology, building the GLP-1/GIP dual agonist tirzepatide (Mounjaro/Zepbound) and following it with retatrutide and orforglipron, its oral non-peptide GLP-1 program
Live bacteria actively colonize the gut and create the disruption necessary for microbiome change
In a 2026 clinical trial published in Nature Medicine , participants who switched from injectable GLP-1 drugs to the once-daily pill orforglipron maintained roughly 75% to 79% of their prior weight loss